Advertisement

Commentary: Running the Bypass Route: What Does Neonatal ECMO Have to Offer?

      Excellent outcomes are achievable with ECMO support of neonates with respiratory failure.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bartlett R.H.
        Esperanza.
        Trans ASAIO. 1985; 31: 723-735
        • UK Collaborative ECMO Trial Group
        UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation.
        Lancet. 1996; 348: 75-82
        • Combes A.
        • Brodie D.
        • Bartlett R.
        • et al.
        Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients.
        Am J Respir Crit Care Med. 2014; 190: 488-496
        • Corno A.F.
        • Faulkner G.M.
        • Harvey C.
        Extra-corporeal membrane oxygenation for neonatal respiratory support.
        Semin Thorac Cardiovasc Surg. 2020; 32: 553-559

      Linked Article

      • Extra-Corporeal Membrane Oxygenation for Neonatal Respiratory Support
        Seminars in Thoracic and Cardiovascular SurgeryVol. 32Issue 3
        • Preview
          To review our experience with Extra-Corporeal Membrane Oxygenation (ECMO) for respiratory support in neonates. From 1989 to 2018 2114 patients underwent respiratory ECMO support, with 764 (36%) neonates. Veno-Venous (V-V) cannulation was used in 428 (56%) neonates and Veno-Arterial (V-A) in 336 (44%). Historically V-V ECMO was our preferred modality, but due to lack of suitable cannula in the last 7 years V-A was used in 209/228 (92%) neonates. Mean and inter-quartile range of ECMO duration was 117 hours (inter-quartile range 90 to 164 hours).
        • Full-Text
        • PDF